Intellipharmaceutics International Inc. Annual Return On Equity in % from 2018 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Intellipharmaceutics International Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2022.
  • Intellipharmaceutics International Inc. Return On Equity for the quarter ending August 31, 2023 was 26.9 %, a 37% decline year-over-year.
  • Intellipharmaceutics International Inc. annual Return On Equity for 2022 was 29.2 %, a 62.3% decline from 2021.
  • Intellipharmaceutics International Inc. annual Return On Equity for 2021 was 77.6 %, a 23.7% increase from 2020.
  • Intellipharmaceutics International Inc. annual Return On Equity for 2020 was 62.7 %, a 88% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 29.2 -48.3 -62.3% Dec 1, 2021 Nov 30, 2022
2021 77.6 +14.9 +23.7% Dec 1, 2020 Nov 30, 2021
2020 62.7 -459 -88% Dec 1, 2019 Nov 30, 2020
2019 522 -671 -56.2% Dec 1, 2018 Nov 30, 2019
2018 1.19K Dec 1, 2017 Nov 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.